_256_384.jpg)
News | February 24, 2024
VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024
The Vice President also highlighted the importance of preventive healthcare and fitness
The Vice President also highlighted the importance of preventive healthcare and fitness
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The deal includes upfront payments, milestone payments and ongoing royalties
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Innovent will supply sintilimab for the collaborated clinical trial
10+ emerging markets, Japan & ANZ transition in final phase
Subscribe To Our Newsletter & Stay Updated
